Qiagen N.V [QGEN] vs RadNet [RDNT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Qiagen N.V wins in 14 metrics, RadNet wins in 5 metrics, with 0 ties. Qiagen N.V appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricQiagen N.VRadNetBetter
P/E Ratio (TTM)26.031,425.75Qiagen N.V
Price-to-Book Ratio2.726.01Qiagen N.V
Debt-to-Equity Ratio42.31156.12Qiagen N.V
PEG Ratio-0.17-2.48RadNet
EV/EBITDA10.0830.93Qiagen N.V
Profit Margin (TTM)18.30%-0.78%Qiagen N.V
Operating Margin (TTM)25.49%7.12%Qiagen N.V
EBITDA Margin (TTM)25.49%7.12%Qiagen N.V
Return on Equity10.81%1.74%Qiagen N.V
Return on Assets (TTM)9.01%1.55%Qiagen N.V
Free Cash Flow (TTM)$502.31M$44.95MQiagen N.V
1-Year Return6.13%14.07%RadNet
Price-to-Sales Ratio (TTM)4.683.06RadNet
Enterprise Value$10.06B$7.00BQiagen N.V
EV/Revenue Ratio4.933.67RadNet
Gross Profit Margin (TTM)62.65%13.88%Qiagen N.V
Revenue per Share (TTM)$9$26RadNet
Earnings per Share (Diluted)$1.69$-0.19Qiagen N.V
Beta (Stock Volatility)0.641.55Qiagen N.V
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Qiagen N.V vs RadNet Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Qiagen N.V-0.17%5.26%-1.45%-4.93%15.54%3.86%
RadNet0.44%4.27%11.41%40.75%49.17%11.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Qiagen N.V6.13%8.77%-15.53%71.77%159.63%235.07%
RadNet14.07%312.48%363.49%1,279.05%3,110.25%11,090.00%

News Based Sentiment: Qiagen N.V vs RadNet

Qiagen N.V

News based Sentiment: POSITIVE

Qiagen demonstrated resilience in a down market, secured a key partnership expansion in Japan, received an analyst upgrade, and benefits from a strong growth forecast in the cancer biomarkers market. These factors collectively suggest a positive outlook for the company, though valuation remains fair.

View Qiagen N.V News Sentiment Analysis

RadNet

News based Sentiment: MIXED

RadNet demonstrated strong Q2 performance and continued strategic investments in AI and acquisitions, but significant insider selling and a mixed earnings outlook create a complex investment narrative. The combination of positive developments and cautionary signals warrants a 'mixed' sentiment and a relatively high importance score.

View RadNet News Sentiment Analysis

Performance & Financial Health Analysis: Qiagen N.V vs RadNet

MetricQGENRDNT
Market Information
Market Cap i$9.69B$5.96B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,123,284718,540
90 Day Avg. Volume i1,273,311663,123
Last Close$46.24$78.33
52 Week Range$37.63 - $51.88$45.00 - $93.65
% from 52W High-10.87%-16.36%
All-Time High$60.81 (Jul 17, 2000)$93.65 (Nov 11, 2024)
% from All-Time High-23.96%-16.36%
Growth Metrics
Quarterly Revenue Growth0.08%0.08%
Quarterly Earnings Growth0.07%N/A
Financial Health
Profit Margin (TTM) i0.18%-0.01%
Operating Margin (TTM) i0.25%0.07%
Return on Equity (TTM) i0.11%0.02%
Debt to Equity (MRQ) i42.31156.12
Cash & Liquidity
Book Value per Share (MRQ)$16.17$12.42
Cash per Share (MRQ)$4.40$10.83
Operating Cash Flow (TTM) i$675.03M$261.76M
Levered Free Cash Flow (TTM) i$683.15M$143.32M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Qiagen N.V vs RadNet

MetricQGENRDNT
Price Ratios
P/E Ratio (TTM) i26.031,425.75
Forward P/E i19.2199.60
PEG Ratio i-0.17-2.48
Price to Sales (TTM) i4.683.06
Price to Book (MRQ) i2.726.01
Market Capitalization
Market Capitalization i$9.69B$5.96B
Enterprise Value i$10.06B$7.00B
Enterprise Value Metrics
Enterprise to Revenue i4.933.67
Enterprise to EBITDA i10.0830.93
Risk & Other Metrics
Beta i0.641.55
Book Value per Share (MRQ) i$16.17$12.42

Financial Statements Comparison: Qiagen N.V vs RadNet

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)QGENRDNT
Revenue/Sales i$533.54M$498.23M
Cost of Goods Sold i$199.25M$429.09M
Gross Profit i$334.29M$69.15M
Research & Development i$47.75MN/A
Operating Income (EBIT) i$135.97M$33.15M
EBITDA i$200.58M$81.27M
Pre-Tax Income i$126.82M$23.85M
Income Tax i$30.57M$820,000
Net Income (Profit) i$96.25M$23.03M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)QGENRDNT
Cash & Equivalents i$638.76M$717.32M
Total Current Assets i$1.74B$1.02B
Total Current Liabilities i$516.94M$505.40M
Long-Term Debt i$1.35B$1.66B
Total Shareholders Equity i$3.41B$1.14B
Retained Earnings i$2.50B$-114.71M
Property, Plant & Equipment iN/A$1.37B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)QGENRDNT
Operating Cash Flow i$190.30M$113.66M
Capital Expenditures i$-43.90M$-52.93M
Free Cash Flow i$95.48M$67.41M
Debt Repayment iN/A$-7.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricQGENRDNT
Shares Short i6.67M6.43M
Short Ratio i4.939.58
Short % of Float i0.05%0.10%
Average Daily Volume (10 Day) i1,123,284718,540
Average Daily Volume (90 Day) i1,273,311663,123
Shares Outstanding i216.12M74.04M
Float Shares i214.89M69.22M
% Held by Insiders i0.02%0.13%
% Held by Institutions i0.89%0.94%

Dividend Analysis & Yield Comparison: Qiagen N.V vs RadNet

MetricQGENRDNT
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.44N/A
3-Year Avg Dividend Yield i3.03%N/A
3-Year Total Dividends i$1.32N/A
Ex-Dividend DateJan 30, 2024N/A